Data Characteristics
mRNA vaccine product data originates from clinical trial reports, regulatory submissions (e.g., FDA BLA/NDA), academic papers, patent literature, and internal R&D records. Data updates frequently, especially during clinical trial phases or post-market surveillance, with new trial data, adverse event reports, or manufacturing process changes potentially arriving monthly or even weekly. Document structures are complex. They often contain extensive unstructured text, such as clinical study protocols, statistical analysis reports, safety data, and quality control files. Structured table data, like subject baseline characteristics, laboratory indicators, and adverse event lists, supplements this. Fields and units are highly specialized. Examples include dosage units like μg, administration routes like IM (intramuscular), trial endpoints like ORR (objective response rate), and safety indicators like SAE (serious adverse event).
Constraints Imposed by Data Characteristics on Workflow Orchestration
The wide range and frequent updates of mRNA vaccine data require workflows with efficient data ingestion and version management capabilities to ensure processing of the latest information. Complex document structures mean the information extraction phase needs Natural Language Processing (NLP) techniques for semantic understanding of unstructured text and accurate extraction of key data from structured tables. Specialized fields and units, such as mRNA sequence length or LNP particle size distribution, demand that the semantic parsing modules within the workflow recognize and correctly process these biomedical terms to avoid misinterpretation or data loss. Furthermore, safety and compliance requirements dictate that workflows maintain traceability during data processing and handle sensitive information, such as anonymizing subject IDs. Large data volumes and rapid updates also place higher demands on the workflow's concurrent processing capabilities and error retry mechanisms.
Configuration Guidelines
| Configuration Item | Suggested Value | Rationale |
|---|---|---|
maxContext | 32000 token | Ensures critical context from long documents like clinical study reports is retained, reducing truncation. |
Chunk size | 800 characters | Balances semantic completeness and recall efficiency, avoiding excessive fragmentation or overly long segments. |
Recall count | Top 5 entries | Balances relevance and computational cost; the first few results typically cover core information. |
Similarity threshold | 0.75–0.85 | Sets a higher threshold for the mRNA domain, which has many specialized terms, to improve recall precision. |
Retry Count | 3 times | Addresses occasional network fluctuations or service instability in external API calls (e.g., LLM). |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Allows processing of large PDF clinical trial reports or patent documents. |
Common Pitfalls
- During workflow execution, the large language model returns a
chat:LLM_model_response_emptyerror. This occurs when the prompt is too long or contains complex instructions, causing the model to fail processing. - Decision node logic does not match expectations. For example, a boolean value displays as true but a subsequent condition evaluates to false. This typically results from data type mismatches or implicit conversions invalidating conditional checks.
- Timeouts occur in data extraction or transformation nodes. This is due to processing excessively large documents or inefficient regular expressions/parsing logic.
Verification Steps
- Run typical queries against different types of mRNA vaccine documents (e.g., clinical trial reports, manufacturing process files) and check the relevance of recall results.
- Simulate extreme conditions (e.g., exceptionally long documents, queries with rare terminology) to verify workflow robustness and error handling mechanisms.
- Examine log outputs for critical nodes (e.g., data parsing, model invocation) to confirm the absence of frequent timeouts or abnormal status codes.
The values provided are common starting points. Measure them against your own samples.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.